At the American Society of Clinical Oncology Gastrointestinal (GI ASCO) Symposium January 20, 2011, researchers reported progression-free and overall survival benefit in newly diagnosed advanced GIST patients in an ongoing Masitinib (AB1010) Phase II trial in France.
Bayer initiates a randomized Phase III trial of Regorafenib in GIST: On January 10, 2011 Bayer Healthcare in Berlin, Germany announced the initiation of a randomized phase III trial of Regorafenib (BAY 73-4506) for Gastrointestinal Stromal Tumor patients.
Yesterday, there were a series of news stories reporting on an article published by Cooke et al inCancer Cell. Unfortunately, the coverage gave misleading information which could suggest that patients should not take Gleevec (imatinib) or Sutent (sunitinib).
Two human cancer cells seen just before they divide into four cells, viewed at 100x magnification. From the Nikon International Small World Photomicrography Competition.
The Latin American GIST Initiative now has a name...and a logo! Alianza GIST is a partnership of patient advocates representing ten Latin American countries and aims to improve the knowledge of patients and physicians, as [...]
Ellen Rosenthal, Michigan Local Group Coordinator, had this to say about their latest local group meeting, “In attendance at the September 23 Michigan LRG meeting were Abbas and Zahrina Patni, Lynne Newman, Jim Martin, Helen [...]
According to Colorado Coordinator, Jerry Call, “The October Colorado meeting went very well. “There was some eating and drinking and lots of laughs in addition to a few sorrows. It seems that there is a [...]
EU Cancer Patients Concerns Heard: Cancer Patient Mobility Moves Closer to a Reality. The following article was taken from a European Cancer Patient Coalition press release. A “yes” vote in the European Parliament’s public health committee [on October 27, [...]
This article is excerpted from a Bloomberg News story. FDA to pharma: Review your marketing to make sure it’s not breaking the rules, or else. In the second headsup from an agency official since March, FDA [...]
Dr. Su Young Kim, who runs the NIH’s Wildtype & Pediatric GIST clinic, has been a little busy lately...welcoming a baby girl in to the world! Su & his wife, Yeanhee, greeted little Cara Kim, 8 [...]
